FindTrial
Sign In

A clinical study on sarcopenia before interventional therapy for liver cancer for evaluating its short-term efficacy

A clinical study on sarcopenia before interventional therapy for liver cancer for evaluating its short-term efficacy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092287
Enrollment
Unknown
Registered
2024-11-13
Start date
2024-11-13
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Age = 18 years old; ? Pathologically or radiologically confirmed as hepatocellular carcinoma; ? CNLC clinical stage: ?b - ?b or BCLC clinical staging: A-C;? Interventional therapy is the first choice or main treatment; ? Willing to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? Age < 18 years old; ? Non-hepatocellular carcinoma; ? Other treatments were carried out before interventional therapy; ? Have cognitive impairment; ? Did not sign the informed consent form; ? Patients who used nutritional support for a long time during the interventional therapy process

Design outcomes

Primary

MeasureTime frame
Overall response rate;Progression-free survival;—

Secondary

MeasureTime frame
Quality of life;—

Countries

China

Contacts

Public ContactWangyidi

The First Affiliated Hospital of Chongqing Medical University

wangyidi@zyyy2.wecom.work+86 135 2749 0987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026